CN101959854A - 具有前列腺素活性的取代环戊烷 - Google Patents
具有前列腺素活性的取代环戊烷 Download PDFInfo
- Publication number
- CN101959854A CN101959854A CN2009801079234A CN200980107923A CN101959854A CN 101959854 A CN101959854 A CN 101959854A CN 2009801079234 A CN2009801079234 A CN 2009801079234A CN 200980107923 A CN200980107923 A CN 200980107923A CN 101959854 A CN101959854 A CN 101959854A
- Authority
- CN
- China
- Prior art keywords
- compound
- alkyl
- expressed
- acid
- hair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BXUHXMVABPDEHP-BOMADRPESA-N C[C@H](CCC[C@@H](/C=C/[C@H]([C@@H](C/C=C\CCCC(O)=O)[C@@H](C1)Cl)[C@@H]1O)O)O Chemical compound C[C@H](CCC[C@@H](/C=C/[C@H]([C@@H](C/C=C\CCCC(O)=O)[C@@H](C1)Cl)[C@@H]1O)O)O BXUHXMVABPDEHP-BOMADRPESA-N 0.000 description 1
- PBXKZBRQCQEENQ-UZMOGYDDSA-N C[C@H](CCC[C@@H](/C=C/[C@H]([C@@H](CCCCCCC(O)=O)[C@@H](C1)Cl)[C@@H]1O)O)O Chemical compound C[C@H](CCC[C@@H](/C=C/[C@H]([C@@H](CCCCCCC(O)=O)[C@@H](C1)Cl)[C@@H]1O)O)O PBXKZBRQCQEENQ-UZMOGYDDSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2617908P | 2008-02-05 | 2008-02-05 | |
| US61/026,179 | 2008-02-05 | ||
| US12/363,996 US8455547B2 (en) | 2008-02-05 | 2009-02-02 | Substituted cyclopentanes having prostaglandin activity |
| US12/363,996 | 2009-02-02 | ||
| PCT/US2009/032943 WO2009100057A1 (en) | 2008-02-05 | 2009-02-03 | Substituted cyclopentanes having prostaglandin activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101959854A true CN101959854A (zh) | 2011-01-26 |
Family
ID=40932327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009801079234A Pending CN101959854A (zh) | 2008-02-05 | 2009-02-03 | 具有前列腺素活性的取代环戊烷 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8455547B2 (https=) |
| EP (2) | EP2245005A1 (https=) |
| JP (1) | JP5566912B2 (https=) |
| KR (1) | KR20100119787A (https=) |
| CN (1) | CN101959854A (https=) |
| AU (1) | AU2009212570B2 (https=) |
| BR (1) | BRPI0907913A2 (https=) |
| CA (1) | CA2713958A1 (https=) |
| IL (1) | IL207354A0 (https=) |
| MX (1) | MX2010008589A (https=) |
| RU (1) | RU2505530C2 (https=) |
| WO (1) | WO2009100057A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2418592C1 (ru) * | 2010-04-19 | 2011-05-20 | Геннадий Васильевич Порядин | Способ лечения артериальной гипертонии |
| US9315486B2 (en) | 2013-10-29 | 2016-04-19 | Allergan, Inc. | Therapeutic cyclopentanols, compositions thereof, and methods for use thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0116358A1 (de) * | 1983-02-12 | 1984-08-22 | Bayer Ag | Komplexe von Prostaglandinen |
| US20050070516A1 (en) * | 1997-10-28 | 2005-03-31 | Vivus Inc. | As-needed administration of an androgenic agent to enhance female desire and responsiveness |
| WO2006063179A1 (en) * | 2004-12-10 | 2006-06-15 | Allergan, Inc. | 12-aryl prostaglandin analogs |
| WO2007060453A1 (en) * | 2005-11-26 | 2007-05-31 | Medical Research Council | Promoting wound healing by administering a prostaglandin e and granulocyte-macrophage colony stimulating factor |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1388443A (en) * | 1971-06-11 | 1975-03-26 | Searle & Co | Selective reduction of 9,15-dioxoprostanoic acids |
| JPS55133354A (en) * | 1979-04-02 | 1980-10-17 | Upjohn Co | Prostaglandin derivatives |
| US4259516A (en) * | 1979-04-02 | 1981-03-31 | The Upjohn Company | 19-Hydroxy-inter-oxa-13,14-dihydro-PG1 compounds |
| DE3304864A1 (de) * | 1983-02-12 | 1984-08-16 | Bayer Ag, 5090 Leverkusen | Adsorbate von prostaglandinen |
| ATE266397T1 (de) | 1997-02-04 | 2004-05-15 | Murray A Johnstone | Verfahren zur förderung des haarwuchses und entwicklung des haarsystems |
| SE9702681D0 (sv) * | 1997-07-10 | 1997-07-10 | Pharmacia & Upjohn Ab | Method and composition for treatment of impotence |
| US5877211A (en) * | 1997-11-21 | 1999-03-02 | Allergan | EP2 receptor agonists as neuroprotective agents for the eye |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US6410591B1 (en) * | 2001-05-08 | 2002-06-25 | Allergan Sales, Inc. | 3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| AU2004211936B2 (en) * | 2003-02-11 | 2008-09-11 | Allergan, Inc. | 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| TWI495471B (zh) | 2003-08-12 | 2015-08-11 | R Tech Ueno Ltd | 促進毛髮生長之組成物及方法 |
| PL1759702T3 (pl) | 2004-05-26 | 2009-06-30 | Bayardo Arturo Jimenez | Sposób wytwarzania roztworu latanoprostu do oczu oraz roztwór otrzymany tym sposobem |
| US7476755B2 (en) * | 2006-05-04 | 2009-01-13 | Allergan, Inc. | Therapeutic compounds |
| EP2037967B1 (en) | 2006-06-16 | 2016-12-07 | The Trustees Of The University Of Pennsylvania | Prostaglandin d2 receptor antagonists for treating androgenetic alopecia |
-
2009
- 2009-02-02 US US12/363,996 patent/US8455547B2/en active Active
- 2009-02-03 KR KR1020107019695A patent/KR20100119787A/ko not_active Ceased
- 2009-02-03 JP JP2010545948A patent/JP5566912B2/ja not_active Expired - Fee Related
- 2009-02-03 EP EP09708693A patent/EP2245005A1/en not_active Withdrawn
- 2009-02-03 WO PCT/US2009/032943 patent/WO2009100057A1/en not_active Ceased
- 2009-02-03 AU AU2009212570A patent/AU2009212570B2/en not_active Ceased
- 2009-02-03 CN CN2009801079234A patent/CN101959854A/zh active Pending
- 2009-02-03 BR BRPI0907913-0A patent/BRPI0907913A2/pt not_active IP Right Cessation
- 2009-02-03 CA CA2713958A patent/CA2713958A1/en not_active Abandoned
- 2009-02-03 EP EP12167472A patent/EP2487153A1/en not_active Withdrawn
- 2009-02-03 RU RU2010135795/04A patent/RU2505530C2/ru not_active IP Right Cessation
- 2009-02-03 MX MX2010008589A patent/MX2010008589A/es active IP Right Grant
-
2010
- 2010-08-02 IL IL207354A patent/IL207354A0/en unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0116358A1 (de) * | 1983-02-12 | 1984-08-22 | Bayer Ag | Komplexe von Prostaglandinen |
| US20050070516A1 (en) * | 1997-10-28 | 2005-03-31 | Vivus Inc. | As-needed administration of an androgenic agent to enhance female desire and responsiveness |
| WO2006063179A1 (en) * | 2004-12-10 | 2006-06-15 | Allergan, Inc. | 12-aryl prostaglandin analogs |
| WO2007060453A1 (en) * | 2005-11-26 | 2007-05-31 | Medical Research Council | Promoting wound healing by administering a prostaglandin e and granulocyte-macrophage colony stimulating factor |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009212570B2 (en) | 2014-04-10 |
| IL207354A0 (en) | 2010-12-30 |
| EP2245005A1 (en) | 2010-11-03 |
| RU2010135795A (ru) | 2012-03-20 |
| AU2009212570A1 (en) | 2009-08-13 |
| WO2009100057A1 (en) | 2009-08-13 |
| EP2487153A1 (en) | 2012-08-15 |
| MX2010008589A (es) | 2010-08-23 |
| US8455547B2 (en) | 2013-06-04 |
| JP5566912B2 (ja) | 2014-08-06 |
| BRPI0907913A2 (pt) | 2015-07-28 |
| RU2505530C2 (ru) | 2014-01-27 |
| US20090197962A1 (en) | 2009-08-06 |
| JP2011511081A (ja) | 2011-04-07 |
| KR20100119787A (ko) | 2010-11-10 |
| CA2713958A1 (en) | 2009-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI249520B (en) | 5-Thia-omega-substituted phenyl prostaglandin E derivatives, method for producing the same and medicines containing the same as the active ingredient | |
| KR100573535B1 (ko) | ω-시클로알킬-프로스타글란딘E₂유도체 | |
| JPS6147459A (ja) | １１−置換−１６−フエノキシプロスタトリエン酸誘導体 | |
| WO1999002165A1 (en) | Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma | |
| WO2009006370A1 (en) | Therapeutic substituted cyclopentanes for reducing intraocular pressure | |
| JP2001514628A (ja) | 緑内障治療に用いるための１３−チアプロスタグランジン | |
| CN102977048A (zh) | 具有前列腺素活性的取代环戊烷 | |
| WO2005049558A1 (en) | Novel prostamides for the treatment of glaucoma and related diseases | |
| CN101959854A (zh) | 具有前列腺素活性的取代环戊烷 | |
| CH619691A5 (https=) | ||
| JPH11193268A (ja) | ω−シクロアルキル−プロスタグランジンＥ２誘導体 | |
| AU2008331597B2 (en) | Substituted cyclopentanes having prostaglandin activity | |
| WO2006041875A1 (en) | Novel prostamides for the treatment of glaucoma and related diseases | |
| JP2000128858A (ja) | ω―シクロアルキル―プロスタグランジンＥ２誘導体 | |
| KR100224951B1 (ko) | 15-데옥시프로스타글란딘유도체 | |
| RU2481342C9 (ru) | Терапевтические замещенные лактамы | |
| RU2481342C2 (ru) | Терапевтические замещенные лактамы | |
| HK1181392A (en) | Substituted cyclopentanes having prostaglanding activity | |
| JPWO2001055102A1 (ja) | 新規なジフルオロプロスタグランジン誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20110126 |